Skip to main content
logo
BioVersys AG (SWX:BIOV)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
24.80
-0.40 (-1.59%)
At close: Aug 21, 2026

BioVersys AG Financials Overview

Millions CHF. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Revenue
3.183.181.211.14
Revenue Growth
142.55%161.75%6.50%-
Gross Profit
3.183.181.211.14
Operating Income
-19.96-19.96-18.72-17.7
Net Income
-21.83-21.83-18.72-18.3
Earnings Per Share
-3.89-3.89-5.62-6.13
EPS Growth
----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Cash & Investments
82.5182.5132.6228.38
Total Debt
21.7321.7316.9715.93
Net Cash (Debt)
60.7860.7815.6512.45
Net Cash Growth
-17.67%288.25%25.77%-
Net Cash Per Share
10.8210.824.704.17

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Operating Cash Flow
-21.95-21.95-15.57-11.66
Capital Expenditures
-0.22-0.22-0.04-0.05
Free Cash Flow
-22.16-22.16-15.61-11.7
Free Cash Flow Growth
----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023
Period EndingDec '25 Dec '25 Dec '24 Dec '23
Gross Margin
100.00%100.00%100.00%100.00%
Operating Margin
-628.76%-628.76%-1543.45%-1554.17%
Pretax Margin
-687.06%-687.06%-1543.20%-1606.76%
Profit Margin
-687.56%-687.56%-1543.20%-1606.76%
FCF Margin
-698.02%-698.02%-1287.06%-1027.57%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023
Period EndingAug '26 Dec '25 Dec '24 Dec '23
PS Ratio
45.8144.94--